Details of the Drug
General Information of Drug (ID: DMSF5DR)
| Drug Name |
4-Methyl-N-(4-phenyl-thiazol-2-yl)-benzamide
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
4-Methyl-N-(4-phenyl-1,3-thiazol-2-yl)benzamide; CHEMBL294175; 4-Methyl-N-(4-phenyl-thiazol-2-yl)-benzamide; NERONVMZIDSIRT-UHFFFAOYSA-N; 87614-00-4; (Z)-4-methyl-N-(4-phenylthiazol-2(3H)-ylidene)benzamide; AC1Q2JVA; AC1LB6OY; Oprea1_598164; Oprea1_751162; Oprea1_000114; SCHEMBL233522; ARONIS019641; 2-[(4-methylphenyl)carboxamido]-4-phenyl-1,3-thiazole; KS-00004BJP; MolPort-003-009-217; MolPort-001-029-741; ZINC4031557; BDBM50101781; STK084905; AKOS024573976; AKOS000486758; MCULE-8350259880; ST036564
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 294.4 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 4.1 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


